Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

AAIC 2017 | Lifestyle interventions to protect against cognitive decline

Laura Baker • 17 Jul 2017
AAIC 2017
Alzheimer’s Disease
U.S. POINTER

Laura Baker, PhD from the Wake Forest School of Medicine, Winston-Salem, NC, who is also the co-investigator of the U.S. POINTER study talks about her area of interest – lifestyle interventions to protect against cognitive decline. She briefly touches on the uniqueness of the U.S. POINTER study which is the only study to combine several different lifestyle interventions as one combined therapy. This interview was recorded at the Alzheimer’s Association International Conference (AAIC) 2017, London, UK.

More from Laura Baker

EXERT: why was strength/balance training as effective as cardio in preventing cognitive decline?
4:01
EXERT: why was strength/balance training as effective as cardio in preventing cognitive decline?
Laura Baker • 26 Jul 2022
How does exercise affect cognition?
2:27
How does exercise affect cognition?
Laura Baker • 26 Jul 2022
EXERT results: exercise shown to stall cognitive decline in patients with mild cognitive impairment
8:12
EXERT results: exercise shown to stall cognitive decline in patients with mild cognitive impairment
Laura Baker • 26 Jul 2022
Investigating aerobic exercise and cognition in older adults
6:16
Investigating aerobic exercise and cognition in older adults
Laura Baker • 26 Jul 2022

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
What are the biological mechanisms underlying the higher prevalence of AD in women?
1:55
What are the biological mechanisms underlying the higher prevalence of AD in women?
Amber Watts • 14 Jul 2026
MenoCog: risk and protective factors for cognitive function in the menopause transition
2:37
MenoCog: risk and protective factors for cognitive function in the menopause transition
Amber Watts • 14 Jul 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals